In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?

被引：0
|
作者：
Lanthier, L. [1 ]
Plourde, M-E [2 ]
Cauchon, M. [3 ]
机构：
[1] Univ Sherbrooke, Dept Med Specialise, Serv Med Interne Gen, Sherbrooke, PQ, Canada
[2] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Serv Radiooncol, Sherbrooke, PQ, Canada
[3] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada
来源：
REVUE DE MEDECINE INTERNE | 2021年 / 42卷 / 02期
关键词：
NEPHROPATHY;
D O I：
10.1016/j.revmed.2020.12.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [21] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [22] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23): : 2219 - 2229
  • [23] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes Reply
    Bakris, George L.
    Agarwal, Rajiv
    Filippatos, Gerasimos
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [24] Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease
    Cherney, David Z. I. L.
    Bhatt, Deepak
    Szarek, Michael
    Sun, Franklin
    Girard, Manon J.
    Davies, Michael
    Pitt, Bertram
    Steg, Ph. Gabriel
    DIABETES OBESITY & METABOLISM, 2023, 25 (11): : 3410 - 3414
  • [25] Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
    Fu, Edouard L.
    Kutz, Alexander
    Desai, Rishi J.
    KIDNEY INTERNATIONAL, 2023, 103 (01) : 30 - 33
  • [26] Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes A Mediation Analysis
    Agarwal, Rajiv
    Tu, Wanzhu
    Farjat, Alfredo E.
    Fang, Youssef M. K.
    Toto, Robert
    Kaul, Sanjay
    Lawatscheck, Robert
    Rohwedder, Katja
    Ruilope, Luis M.
    Rossing, Peter
    Pitt, Bertram
    Filippatos, Gerasimos
    Anker, Stefan D.
    Bakris, George L.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1606 - 1616
  • [27] Validation of the FINE-CKD Model for Future Health Technology Assessments for Finerenone in Patients With Chronic Kidney Disease And Type 2 Diabetes
    Pochopien, Michal
    Cherney, David
    Drzewiecka, Aleksandra
    Folkerts, Kerstin
    Levy, Pierre
    Millier, Aurelie
    Morris, Stephen
    Palarczyk, Monika
    Roy-Chaudhury, Prabir
    Sullivan, Sean D.
    Mernagh, Paul
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (06): : S104 - S111
  • [28] Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes (vol 15, pg 501, 2022)
    Lerma, E. V.
    Wilson, D. J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (11) : I - I
  • [29] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, Mayorga W.
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [30] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN HISPANIC PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Rosas, Sylvia
    Ruilope, Luis M.
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Bonfanti, Andres A. C.
    Correa-Rotter, Ricardo
    Gonzalez, Fernando
    Pergola, Pablo
    Umpierrez, Guillermo
    Scalise, Andrea
    Scott, Charlie
    Joseph, Amer
    Bakris, George L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S47 - S48
12345